Chadchan, S. B., Singh, V., & Kommagani, R. (2022). Female reproductive dysfunctions and the gut microbiota. Journal of Molecular Endocrinology. https://doi.org/10.1530/JME-21-0238
Chadchan SB, Singh V, Kommagani R. Female reproductive dysfunctions and the gut microbiota. Journal of Molecular Endocrinology. 2022. doi:10.1530/JME-21-0238
Chadchan, Sangappa B., et al. "Female reproductive dysfunctions and the gut microbiota." Journal of Molecular Endocrinology, 2022.
For EndNote, Zotero or Mendeley:
Open access
Free to read
No reuse license
Open Access
Free full text on PubMed Central (PMC10031513)
RRM Academy Synopsis
Gut microbiota changes are associated with PCOS and endometriosis
A 2022 review examined gut bacteria in endometriosis and polyendocrine metabolic ovarian syndrome (PMOS / PCOS). Most studies found a link between altered gut bacteria and these conditions. In mice, a fatty acid called n-butyrate slowed endometriosis lesion growth.
Study at a glance, review: Gut microbiota changes were associated with PCOS and endometriosis. Source: Chadchan SB et al., 2022, DOI 10.1530/JME-21-0238.
Key Findings
Across the reproductive diseases reviewed, most studies reported associations with altered gut microbial composition, and few suggested cause-effect relationships.
A comparison of 102 women with polyendocrine metabolic ovarian syndrome (PMOS), formerly polycystic ovary syndrome (PCOS), and 201 age- and BMI-matched controls identified four bacterial genera that differed.
Endometriosis findings diverged: the largest study to date (66 patients, 198 controls) found 12 bacteria at different abundances, while another (35 patients, 24 controls) found no differences.
In a rat model of PMOS / PCOS, transplanting fecal microbiota from healthy rats improved estrous cycles in all of the rats (n=8), and Lactobacillus alone improved them in 75%.
In mice, altered gut microbiota drove endometriotic lesion growth, and treatment with n-butyrate, a short-chain fatty acid, attenuated lesion growth.
Interpretation
This review brings together human studies on gut bacteria with mouse and rat experiments on endometriosis and PMOS / PCOS. The mouse work points to a mechanism. Gut bacteria and the fatty acids they make can change lesion growth and hormone levels. The authors note that no causal link between gut bacteria and endometriosis has been proven in humans yet. The findings support larger, longer human studies that track disease stage, age, diet and medication over time.
RRM Context
Restorative reproductive medicine looks for root causes of reproductive conditions. The review describes one such pathway. Gut bacteria help regulate blood estrogen levels. The mouse findings on gut-made fatty acids point to a modifiable piece of that pathway.
Our editorial summary of this paper, not the article's abstract.
Abstract
The gut microbiome is considered an endocrine organ that can influence distant organs and associated biological pathways. Recent advances suggest that gut microbial homeostasis is essential for reproductive health and that perturbations in the gut microbiota can lead to reproductive pathologies. This review provides an updated overview of the relationship between the gut microbiome and female reproductive diseases. Specifically, we highlight the most recent findings on the gut microbiome in gynecological pathologies including polycystic ovarian syndrome, endometriosis, and endometrial cancer. Most studies revealed associations between altered gut microbial compositions and these reproductive diseases, though few have suggested cause-effect relationships. Future studies should focus on determining the molecular mechanisms underlying associations between gut microbiota and reproductive diseases. Understanding this bidirectional relationship could lead to the development of novel and effective strategies to prevent, diagnose, and treat female reproductive organ-related diseases.